5,814 Synopsys, Inc. $SNPS Shares Acquired by Affinity Capital Advisors LLC

Key Points

• Affinity Capital Advisors increased its Synopsys stake by 364.7% in the third quarter, acquiring 5,814 shares for a total holding of 7,408 shares valued at approximately $3.22 million. Institutional investors collectively own 85.47% of SNPS.
• Analysts remain broadly bullish, with a consensus “Moderate Buy” rating and a $571.78 price target; Needham and Bank of America recently raised their targets to $620 and $600, respectively.
• Synopsys beat quarterly earnings and revenue expectations, reporting $3.91 in EPS and $2.48 billion in revenue, while approving a $1 billion share-repurchase program. However, company insiders sold 102,559 shares worth $44.6 million over the past 90 days.

Affinity Capital Advisors LLC grew its stake in Synopsys, Inc. (NASDAQ:SNPS - Free Report) by 364.7% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 7,408 shares of the semiconductor company's stock after purchasing an additional 5,814 shares during the quarter. Affinity Capital Advisors LLC's holdings in Synopsys were worth $3,222,000 at the end of the most recent quarter.

Several other institutional investors have also added to or reduced their stakes in the stock. Sankala Group LLC bought a new stake in Synopsys during the 4th quarter valued at approximately $25,000. Elevation Wealth Partners LLC grew its holdings in shares of Synopsys by 96.4% during the 2nd quarter. Elevation Wealth Partners LLC now owns 55 shares of the semiconductor company's stock worth $25,000 after acquiring an additional 27 shares during the period. Osbon Capital Management LLC bought a new position in shares of Synopsys in the 2nd quarter worth approximately $25,000. IMG Wealth Management Inc. bought a new position in shares of Synopsys in the 2nd quarter worth approximately $28,000. Finally, GK Wealth Management LLC bought a new position in shares of Synopsys in the 3rd quarter worth approximately $28,000. 85.47% of the stock is currently owned by institutional investors.

Insider Buying and Selling

In other news, CFO Sudhindra Kankanwadi sold 9,170 shares of the stock in a transaction on Tuesday, October 6th. The stock was sold at an average price of $500.00, for a total value of $4,585,000.00. Following the sale, the chief financial officer directly owned 22,717 shares of the company's stock, valued at approximately $11,358,500. This represents a 28.76% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CEO Sassine Ghazi sold 14,604 shares of the stock in a transaction on Tuesday, September 15th. The stock was sold at an average price of $374.88, for a total value of $5,474,747.52. Following the completion of the sale, the chief executive officer directly owned 76,865 shares in the company, valued at approximately $28,815,151.20. This represents a 15.97% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last ninety days, insiders sold 102,559 shares of company stock valued at $44,607,141. 0.56% of the stock is owned by insiders.

Analyst Upgrades and Downgrades

SNPS has been the subject of a number of research analyst reports. Needham & Company LLC raised their target price on Synopsys from $580.00 to $620.00 and gave the company a "buy" rating in a research note on Monday. Sanford C. Bernstein started coverage on Synopsys in a research note on Friday, September 25th. They issued an "outperform" rating on the stock. Zacks Research raised Synopsys from a "hold" rating to a "strong-buy" rating in a research note on Friday, October 2nd. Bank of America increased their price objective on Synopsys from $500.00 to $600.00 in a report on Thursday, October 1st. Finally, Benchmark reissued a "buy" rating and set a $570.00 price objective on shares of Synopsys in a research report on Thursday, August 27th. One equities research analyst has rated the stock with a Strong Buy rating, twenty-one have issued a Buy rating and four have assigned a Hold rating to the company. Based on data from MarketBeat, Synopsys has a consensus rating of "Moderate Buy" and a consensus price target of $571.78.

Synopsys Price Performance

Shares of NASDAQ SNPS opened at $494.51 on Wednesday. The company has a 50 day simple moving average of $423.97 and a two-hundred day simple moving average of $440.26. Synopsys, Inc. has a fifty-two week low of $362.55 and a fifty-two week high of $539.48. The company has a market capitalization of $94.77 billion, a price-to-earnings ratio of 51.07, a P/E/G ratio of 2.05 and a beta of 1.21. The company has a debt-to-equity ratio of 0.29, a quick ratio of 1.24 and a current ratio of 1.34.

Synopsys (NASDAQ:SNPS - Get Free Report) last issued its quarterly earnings results on Wednesday, August 26th. The semiconductor company reported $3.91 EPS for the quarter, topping analysts' consensus estimates of $3.67 by $0.24. Synopsys had a return on equity of 6.24% and a net margin of 11.43%. The firm had revenue of $2.48 billion for the quarter, compared to analysts' expectations of $2.44 billion. During the same period in the previous year, the firm posted $3.39 EPS. The business's revenue for the quarter was up 42.4% compared to the same quarter last year. Synopsys has set its Q4 2026 guidance at 4.100-4.160 EPS and its FY 2026 guidance at 15.040-15.100 EPS. Analysts expect that Synopsys, Inc. will post 10.97 EPS for the current fiscal year.

Synopsys announced that its Board of Directors has approved a stock buyback plan on Monday, October 5th that permits the company to buy back $1.00 billion in shares. This buyback authorization permits the semiconductor company to purchase up to 1.1% of its stock through open market purchases. Share buyback plans are generally an indication that the company's board of directors believes its shares are undervalued.

Synopsys Profile

Synopsys, Inc is a technology company that develops electronic design automation (EDA) software, semiconductor intellectual property (IP), and software tools used to design, verify, and manufacture advanced electronic systems. Its solutions support the development of semiconductors, systems-on-chip, and electronic products across the design cycle, from initial specification and architecture through testing and production.

The company's offerings include digital and custom integrated-circuit design tools, simulation and verification software, physical design and signoff products, and semiconductor IP such as processor cores, interface technologies, and foundational components.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.